Long-term mixed chimerism after immunologic conditioning and MHC-mismatched stem-cell transplantation is dependent on NK-cell tolerance

  • Geert Westerhuis
    From the Departments of Hematology and Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
  • Wendy G. E. Maas
    From the Departments of Hematology and Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
  • Roel Willemze
    From the Departments of Hematology and Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
  • René E. M. Toes
    From the Departments of Hematology and Rheumatology, Leiden University Medical Center, Leiden, The Netherlands
  • Willem E. Fibbe
    From the Departments of Hematology and Rheumatology, Leiden University Medical Center, Leiden, The Netherlands

説明

<jats:title>Abstract</jats:title><jats:p>T-cell tolerance is mandatory for major histocompatibility complex (MHC)-mismatched stem-cell transplantation without cytoreduction. Here, we used a cytotoxicity assay based on the infusion of differentially carboxyfluorescein succinimidyl ester (CFSE)-labeled syngeneic and donor splenocytes to determine the survival of donor cells in vivo. In vivo cytotoxicity data showed that treatment with anti-CD40 ligand monoclonal antibody in combination with a low dose of MHC-mismatched bone marrow cells was sufficient to induce T-cell tolerance. However, CFSE-labeled donor cells were still eliminated. A similar elimination pattern was observed in T-cell and natural killer T-cell (NKT-cell)-deficient mice, suggesting the involvement of natural killer (NK) cells. Indeed, in vivo NK-cell depletion resulted in a prolonged survival of CFSE-labeled donor cells, confirming the role of NK cells in this process. Transplantation of a megadose of MHC-mismatched bone marrow cells was required for a complete survival of CFSE-labeled donor cells. This NK-cell tolerance was donor specific and was associated with mixed chimerism. Additional NK-cell depletion significantly enhanced engraftment and allowed long-term chimerism after transplantation of a relatively low dose of donor bone marrow cells. These data demonstrate the importance of NK cells in the rejection of MHC-mismatched hematopoietic cells and may explain the high numbers of bone marrow cells required for transplantation over MHC barriers. (Blood. 2005;106:2215-2220)</jats:p>

収録刊行物

  • Blood

    Blood 106 (6), 2215-2220, 2005-09-15

    American Society of Hematology

被引用文献 (1)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ